Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Kintara Therapeutics, Inc. | Director | Options (Right to Buy) | 8.5K | Aug 30, 2023 | Direct | ||
LA JOLLA PHARMACEUTICAL CO | Director | Common Stock | 0 | $6.23 | Aug 22, 2022 | Direct | |
LA JOLLA PHARMACEUTICAL CO | Director | Stock Option (Right to Buy) | 0 | Aug 22, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
KTRA | Kintara Therapeutics, Inc. | Aug 30, 2023 | 1 | $0 | 4 | Sep 1, 2023 | Director |
LJPC | LA JOLLA PHARMACEUTICAL CO | Aug 22, 2022 | 11 | -$3.12K | 4 | Aug 24, 2022 | Director |
KTRA | Kintara Therapeutics, Inc. | Jul 1, 2022 | 1 | $0 | 4 | Jul 5, 2022 | Director |
LJPC | LA JOLLA PHARMACEUTICAL CO | Jan 12, 2022 | 1 | $0 | 4 | Jan 14, 2022 | Director |
KTRA | Kintara Therapeutics, Inc. | Nov 22, 2021 | 1 | $2.23K | 4 | Nov 24, 2021 | Director |
KTRA | Kintara Therapeutics, Inc. | Sep 22, 2021 | 1 | $0 | 4 | Sep 22, 2021 | Director |